Coronary artery calcifications and 6-month mortality in patients with COVID-19 without known atheromatous disease.

ABSTRACT:

Background

Coronary artery calcium (CAC) is an independent risk factor for major adverse cardiovascular events; however, its impact on coronavirus disease 2019 (COVID-19) mortality remains unclear, especially in patients without known atheromatous disease.

Aims

To evaluate the association between CAC visual score and 6-month mortality in patients without history of atheromatous disease hospitalized with COVID-19 pneumonia.

Methods

A single-centre observational cohort study was conducted, involving 293 consecutive patients with COVID-19 in Paris, France, between 13 March and 30 April 2020, with a 6-month follow-up. Patients with a history of ischaemic stroke or coronary or peripheral artery disease were excluded. The primary outcome was all-cause mortality at 6 months

SUBMITTER: Le Hir AS 

PROVIDER: S-EPMC8895715 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature